2018 annual financial data
Alnylam Pharmaceuticals 2018 Financial results
Direct answer
Revenue was 74.91M USD.
Operating income was -814.67M USD and net income was -761.5M USD.
Operating cash flow was -562.62M USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 74.91M USD
- Operating income
- -814.67M USD
- Net income
- -761.5M USD
- Operating cash flow
- -562.62M USD
Explore related company data
View all 2018 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Alnylam Pharmaceuticals financial years